Zimmer Biomet receives FDA 510k clearance for Unite3D Bridge Fixation System

Zimmer Biomet Holdings, a global leader in musculoskeletal healthcare received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the Unite3D™ Bridge Fixation System. It is a 3D-printed technology designed to offer stability in foot and ankle arthrodesis (joint fusion) surgery and includes an osteo-conductive matrix designed to provide for biological incorporation.

Source: http://www.news-medical.net/news/20160212/Zimmer-Biomet-Holdings-receives-FDA-510(k)-clearance-for-Unite3D-Bridge-Fixation-System.aspx